Inpharma Weekly

, Volume 1304, Issue 1, pp 9–9 | Cite as

Pegylated liposomal doxorubicin promising in ovarian cancer

Clinical study
  • 5 Downloads

Keywords

Ovarian Cancer Ovarian Carcinoma Topotecan Objective Response Rate Liposomal Doxorubicin 

Copyright information

© Adis International Ltd 2001

Personalised recommendations